Instrumento Inactivo

Acciones Biondvax Pharmaceuticals Ltd

Acciones

Precio de cierre TEL AVIV STOCK EXCHANGE Otros sitios de cotización
- ^ILa	-

Biondvax Pharmaceuticals : Announces Rights Offering Fully Subscribed at US$20 Million	16/07/19
Biondvax Pharmaceuticals : First Participant Enrolled in Second Cohort of BiondVax’s Pivotal, Clinical Efficacy, Phase 3 Universal Flu Vaccine Trial	08/07/19
Biondvax Pharmaceuticals : European Investment Bank VP attends Signature Event at BiondVax Extending Financing Agreement with BiondVax to €24 million	26/06/19
Biondvax Pharmaceuticals : Patent Covering Manufacturing Process of BiondVax’s M-001 Universal Flu Vaccine Allowed in USA and Japan	18/06/19
Biondvax Pharmaceuticals : Announces Rights Offering in Support of Ongoing Pivotal, Clinical Efficacy Phase 3 Trial of the M-001 Universal Flu Vaccine and Scale Up of Manufacturing Process	10/06/19

Directores	Puesto	Edad	Desde
Amir Reichman CEO	Chief Executive Officer	49	02/03/21
Uri Ben-Or DFI	Director of Finance/CFO	52	01/01/07
Dalit Weinstein Fischer CTO	Chief Tech/Sci/R&D Officer	-	01/01/22

Administradores	Puesto	Edad	Desde
Adi Raviv BRD	Director/Board Member	69	24/03/20
Samuel Moed BRD	Director/Board Member	62	24/03/20
Morris Laster BRD	Director/Board Member	60	27/11/17

Sector

	Varia. 1 de ene.	Capi.
MODERNA, INC.	+25,69 %	47,86 mil M
LONZA GROUP AG	+46,90 %	41,42 mil M
IQVIA HOLDINGS INC.	-3,46 %	40,66 mil M
CELLTRION, INC.	-6,20 %	28,92 mil M
ICON PUBLIC LIMITED COMPANY	+9,17 %	25,55 mil M
ALNYLAM PHARMACEUTICALS, INC.	-20,42 %	19,27 mil M
MEDPACE HOLDINGS, INC.	+28,07 %	12,14 mil M
BIO-TECHNE CORPORATION	+0,17 %	12,15 mil M
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-1,24 %	11,99 mil M